Immunotherapy (Immunotherapy)

Immunotherapy is a subscription-based peer-reviewed journal covering both preclinical research and clinical research, as well as the applications of immunotherapy. The journal’s audience includes researchers and clinicians interested in immunotherapy for cancers and other diseases. Journal coverage includes key areas such as: • Cancer immunotherapy, including checkpoint blockade, cancer vaccines, adoptive T cell therapy, monoclonal antibodies and cytokines • Combined chemo/radio immunotherapy in cancer treatment • Biomarkers for personalized cancer immunotherapy • Allergen immunotherapy, including sublingual, subcutaneous and oral immunotherapy • Restorative immunotherapy for HIV and other immunocompromised patients • Suppressive immunotherapy for autoimmunity diseases and transplantation • Basic science of immunotherapeutic approaches • Drug–immune system interactions • Drug delivery systems, drug combinations and drug–drug interactions • Summaries evaluating newly approved immunotherapeutic agents • Newly identified immune targets of drugs • Results of recent findings and clinical trials relevant to the field of immunotherapy • Post marketing research, including adverse events, drug safety, pharmacoeconomics, cost–benefit issues, real-world evidence and outcomes research

Immunotherapy (Immunotherapy) is :-

• International, Peer-Reviewed, Open Access, Refereed, Cancer immunotherapy, Allergen immunotherapy, chemo/radio immunotherapy, Drug delivery systems, drug combinations, outcomes research , Online or Print , Semi-monthly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1750-743X, E-ISSN: 1750-7448, Established: 2009, Impact Factor: 2.7
• Provides Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE